Structure

Physi-Chem Properties

Molecular Weight:  582.28
Volume:  588.642
LogP:  3.446
LogD:  2.828
LogS:  -4.636
# Rotatable Bonds:  6
TPSA:  121.5
# H-Bond Aceptor:  9
# H-Bond Donor:  1
# Rings:  6
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.234
Synthetic Accessibility Score:  5.634
Fsp3:  0.667
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.084
MDCK Permeability:  5.399300061981194e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.998
Human Intestinal Absorption (HIA):  0.013
20% Bioavailability (F20%):  0.336
30% Bioavailability (F30%):  0.929

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.118
Plasma Protein Binding (PPB):  90.54485321044922%
Volume Distribution (VD):  2.833
Pgp-substrate:  6.689882278442383%

ADMET: Metabolism

CYP1A2-inhibitor:  0.024
CYP1A2-substrate:  0.081
CYP2C19-inhibitor:  0.419
CYP2C19-substrate:  0.167
CYP2C9-inhibitor:  0.832
CYP2C9-substrate:  0.032
CYP2D6-inhibitor:  0.032
CYP2D6-substrate:  0.081
CYP3A4-inhibitor:  0.911
CYP3A4-substrate:  0.585

ADMET: Excretion

Clearance (CL):  6.601
Half-life (T1/2):  0.722

ADMET: Toxicity

hERG Blockers:  0.79
Human Hepatotoxicity (H-HT):  0.958
Drug-inuced Liver Injury (DILI):  0.892
AMES Toxicity:  0.01
Rat Oral Acute Toxicity:  0.909
Maximum Recommended Daily Dose:  0.996
Skin Sensitization:  0.107
Carcinogencity:  0.013
Eye Corrosion:  0.004
Eye Irritation:  0.028
Respiratory Toxicity:  0.966

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475066

Natural Product ID:  NPC475066
Common Name*:   1-O-Deacetylohchinolide B
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  LHFRBMWFNLUYCY-ABMVXICKSA-N
Standard InCHI:  InChI=1S/C33H42O9/c1-8-16(2)30(37)42-29-27-28-31(5,15-39-27)24(40-18(4)34)13-23(35)32(28,6)22-12-25(36)41-21-11-20(19-9-10-38-14-19)17(3)26(21)33(22,29)7/h8-10,14,20-24,27-29,35H,11-13,15H2,1-7H3/b16-8+/t20-,21+,22-,23+,24-,27-,28+,29-,31-,32+,33-/m1/s1
SMILES:  C/C=C(/C(=O)O[C@@H]1[C@@H]2OC[C@]3([C@H]2[C@]([C@@H]2[C@]1(C)C1=C(C)[C@@H](C[C@@H]1OC(=O)C2)c1ccoc1)(C)[C@H](C[C@H]3OC(=O)C)O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL495473
PubChem CID:   11421886
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids
          • [CHEMONTID:0002380] Limonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18932 Melia azedarach Species Meliaceae Eukaryota n.a. Brazilian n.a. PMID[15387656]
NPO18932 Melia azedarach Species Meliaceae Eukaryota n.a. ripe fruit n.a. PMID[16205005]
NPO18932 Melia azedarach Species Meliaceae Eukaryota Fruits n.a. n.a. PMID[33253570]
NPO18932 Melia azedarach Species Meliaceae Eukaryota Seeds n.a. n.a. PMID[3701342]
NPO18932 Melia azedarach Species Meliaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO18932 Melia azedarach Species Meliaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO18932 Melia azedarach Species Meliaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO18932 Melia azedarach Species Meliaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO18932 Melia azedarach Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT140 Organism Artemia Artemia Activity = 100.0 % PMID[464829]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 100.0 nM PMID[464829]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475066 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.98 High Similarity NPC472671
0.9733 High Similarity NPC470119
0.9733 High Similarity NPC214495
0.973 High Similarity NPC29695
0.973 High Similarity NPC182427
0.9669 High Similarity NPC475226
0.961 High Similarity NPC307781
0.961 High Similarity NPC472670
0.9467 High Similarity NPC322546
0.9467 High Similarity NPC308205
0.9427 High Similarity NPC118086
0.9416 High Similarity NPC470792
0.9363 High Similarity NPC472673
0.9338 High Similarity NPC472672
0.9276 High Similarity NPC98206
0.9276 High Similarity NPC34421
0.9276 High Similarity NPC253201
0.9276 High Similarity NPC237259
0.9276 High Similarity NPC302054
0.9226 High Similarity NPC470789
0.9221 High Similarity NPC197137
0.9221 High Similarity NPC470118
0.9172 High Similarity NPC27541
0.9172 High Similarity NPC62692
0.9172 High Similarity NPC126984
0.9139 High Similarity NPC69647
0.9139 High Similarity NPC125182
0.9133 High Similarity NPC255414
0.9125 High Similarity NPC475641
0.9125 High Similarity NPC475237
0.9091 High Similarity NPC296807
0.9091 High Similarity NPC141538
0.9091 High Similarity NPC155939
0.908 High Similarity NPC11062
0.902 High Similarity NPC116717
0.9013 High Similarity NPC472654
0.9013 High Similarity NPC470791
0.9013 High Similarity NPC470790
0.8974 High Similarity NPC469847
0.8961 High Similarity NPC268905
0.8947 High Similarity NPC471007
0.8931 High Similarity NPC61967
0.8924 High Similarity NPC472771
0.8889 High Similarity NPC471001
0.8889 High Similarity NPC195325
0.8889 High Similarity NPC285227
0.8882 High Similarity NPC216755
0.8882 High Similarity NPC472652
0.8882 High Similarity NPC471174
0.8875 High Similarity NPC472141
0.8874 High Similarity NPC5676
0.8868 High Similarity NPC472773
0.8868 High Similarity NPC472669
0.8854 High Similarity NPC472776
0.8854 High Similarity NPC472778
0.8854 High Similarity NPC472777
0.8846 High Similarity NPC92979
0.8839 High Similarity NPC33938
0.8831 High Similarity NPC196846
0.8831 High Similarity NPC156189
0.8831 High Similarity NPC470997
0.882 High Similarity NPC472651
0.882 High Similarity NPC310572
0.882 High Similarity NPC472764
0.8808 High Similarity NPC251865
0.88 High Similarity NPC121158
0.8797 High Similarity NPC475967
0.8774 High Similarity NPC291150
0.8774 High Similarity NPC18135
0.8766 High Similarity NPC234494
0.8765 High Similarity NPC472765
0.8765 High Similarity NPC472766
0.875 High Similarity NPC471168
0.875 High Similarity NPC472139
0.8734 High Similarity NPC195954
0.8734 High Similarity NPC88007
0.8734 High Similarity NPC472772
0.8734 High Similarity NPC194499
0.8734 High Similarity NPC299038
0.8734 High Similarity NPC167142
0.8718 High Similarity NPC469503
0.8712 High Similarity NPC472659
0.871 High Similarity NPC5180
0.8704 High Similarity NPC472775
0.8704 High Similarity NPC472774
0.8693 High Similarity NPC470999
0.8688 High Similarity NPC472767
0.8688 High Similarity NPC200782
0.8688 High Similarity NPC472668
0.8688 High Similarity NPC471167
0.8688 High Similarity NPC471166
0.8667 High Similarity NPC67003
0.8667 High Similarity NPC471632
0.865 High Similarity NPC271235
0.8634 High Similarity NPC283209
0.8634 High Similarity NPC285567
0.8625 High Similarity NPC472653
0.8616 High Similarity NPC45101
0.8608 High Similarity NPC476262
0.8599 High Similarity NPC476201
0.8599 High Similarity NPC294511
0.8599 High Similarity NPC121615
0.8599 High Similarity NPC470996
0.8599 High Similarity NPC471002
0.8598 High Similarity NPC470995
0.858 High Similarity NPC259943
0.8571 High Similarity NPC82851
0.8571 High Similarity NPC68848
0.8571 High Similarity NPC5741
0.8571 High Similarity NPC470938
0.8562 High Similarity NPC84349
0.8554 High Similarity NPC94763
0.8544 High Similarity NPC282445
0.8535 High Similarity NPC471000
0.8529 High Similarity NPC242068
0.8529 High Similarity NPC247563
0.8529 High Similarity NPC105395
0.8528 High Similarity NPC93172
0.8528 High Similarity NPC470875
0.8528 High Similarity NPC97574
0.8526 High Similarity NPC470998
0.8519 High Similarity NPC469846
0.8519 High Similarity NPC165218
0.8519 High Similarity NPC302369
0.8519 High Similarity NPC134254
0.8519 High Similarity NPC39986
0.8516 High Similarity NPC221809
0.8509 High Similarity NPC191828
0.8506 High Similarity NPC34056
0.85 High Similarity NPC304692
0.85 High Similarity NPC261597
0.85 High Similarity NPC36655
0.8497 Intermediate Similarity NPC243577
0.8494 Intermediate Similarity NPC469848
0.8491 Intermediate Similarity NPC44675
0.8491 Intermediate Similarity NPC214541
0.8491 Intermediate Similarity NPC469336
0.8485 Intermediate Similarity NPC82602
0.8481 Intermediate Similarity NPC84063
0.8481 Intermediate Similarity NPC75906
0.8481 Intermediate Similarity NPC246164
0.8477 Intermediate Similarity NPC90953
0.8476 Intermediate Similarity NPC476853
0.8476 Intermediate Similarity NPC476224
0.8476 Intermediate Similarity NPC476850
0.8476 Intermediate Similarity NPC476861
0.8476 Intermediate Similarity NPC100333
0.8471 Intermediate Similarity NPC212257
0.8466 Intermediate Similarity NPC469849
0.8466 Intermediate Similarity NPC276551
0.8466 Intermediate Similarity NPC123088
0.8466 Intermediate Similarity NPC470182
0.8457 Intermediate Similarity NPC471003
0.8457 Intermediate Similarity NPC329938
0.8457 Intermediate Similarity NPC79571
0.8457 Intermediate Similarity NPC69028
0.8457 Intermediate Similarity NPC188649
0.8447 Intermediate Similarity NPC307383
0.8447 Intermediate Similarity NPC472779
0.8443 Intermediate Similarity NPC471437
0.8443 Intermediate Similarity NPC236004
0.8438 Intermediate Similarity NPC41880
0.8438 Intermediate Similarity NPC471169
0.8438 Intermediate Similarity NPC204663
0.8438 Intermediate Similarity NPC104736
0.8438 Intermediate Similarity NPC175964
0.8428 Intermediate Similarity NPC178932
0.8428 Intermediate Similarity NPC57998
0.8424 Intermediate Similarity NPC160651
0.8424 Intermediate Similarity NPC471397
0.8424 Intermediate Similarity NPC327922
0.8421 Intermediate Similarity NPC56197
0.8418 Intermediate Similarity NPC272590
0.8415 Intermediate Similarity NPC214600
0.8415 Intermediate Similarity NPC149945
0.8415 Intermediate Similarity NPC121995
0.8405 Intermediate Similarity NPC477405
0.8405 Intermediate Similarity NPC292389
0.8405 Intermediate Similarity NPC88841
0.8405 Intermediate Similarity NPC469338
0.8405 Intermediate Similarity NPC288602
0.8397 Intermediate Similarity NPC302987
0.8397 Intermediate Similarity NPC71821
0.8397 Intermediate Similarity NPC470941
0.8397 Intermediate Similarity NPC250228
0.8395 Intermediate Similarity NPC8389
0.8395 Intermediate Similarity NPC335761
0.8393 Intermediate Similarity NPC469633
0.8385 Intermediate Similarity NPC195131
0.8385 Intermediate Similarity NPC249021
0.8385 Intermediate Similarity NPC187149
0.8377 Intermediate Similarity NPC80635
0.8377 Intermediate Similarity NPC223415
0.8375 Intermediate Similarity NPC264943
0.8375 Intermediate Similarity NPC471175
0.8375 Intermediate Similarity NPC35000
0.8373 Intermediate Similarity NPC472650
0.8364 Intermediate Similarity NPC173516
0.8364 Intermediate Similarity NPC472282
0.8364 Intermediate Similarity NPC478179

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475066 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8375 Intermediate Similarity NPD5761 Phase 2
0.8375 Intermediate Similarity NPD5760 Phase 2
0.8046 Intermediate Similarity NPD8434 Phase 2
0.7759 Intermediate Similarity NPD6764 Approved
0.7759 Intermediate Similarity NPD6765 Approved
0.7625 Intermediate Similarity NPD4628 Phase 3
0.7584 Intermediate Similarity NPD6785 Approved
0.7584 Intermediate Similarity NPD6784 Approved
0.7442 Intermediate Similarity NPD8127 Discontinued
0.7427 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD7819 Suspended
0.7293 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD6273 Approved
0.7191 Intermediate Similarity NPD5844 Phase 1
0.7167 Intermediate Similarity NPD6559 Discontinued
0.7118 Intermediate Similarity NPD6599 Discontinued
0.7117 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD4966 Approved
0.711 Intermediate Similarity NPD4965 Approved
0.711 Intermediate Similarity NPD4967 Phase 2
0.7093 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD7075 Discontinued
0.7045 Intermediate Similarity NPD7199 Phase 2
0.7024 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD6004 Phase 3
0.7012 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD6005 Phase 3
0.7012 Intermediate Similarity NPD6002 Phase 3
0.7011 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD8404 Phase 2
0.6944 Remote Similarity NPD7799 Discontinued
0.6941 Remote Similarity NPD920 Approved
0.6936 Remote Similarity NPD37 Approved
0.6936 Remote Similarity NPD6801 Discontinued
0.6932 Remote Similarity NPD6234 Discontinued
0.6932 Remote Similarity NPD919 Approved
0.6928 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6909 Remote Similarity NPD5762 Approved
0.6909 Remote Similarity NPD5763 Approved
0.6905 Remote Similarity NPD7236 Approved
0.6893 Remote Similarity NPD5494 Approved
0.689 Remote Similarity NPD2799 Discontinued
0.6889 Remote Similarity NPD7473 Discontinued
0.6886 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6885 Remote Similarity NPD7685 Pre-registration
0.6872 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6864 Remote Similarity NPD6799 Approved
0.686 Remote Similarity NPD7458 Discontinued
0.6857 Remote Similarity NPD3817 Phase 2
0.6857 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6851 Remote Similarity NPD3818 Discontinued
0.6851 Remote Similarity NPD7228 Approved
0.6832 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6831 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6824 Remote Similarity NPD642 Clinical (unspecified phase)
0.6824 Remote Similarity NPD2533 Approved
0.6824 Remote Similarity NPD2534 Approved
0.6824 Remote Similarity NPD2532 Approved
0.6821 Remote Similarity NPD4380 Phase 2
0.6821 Remote Similarity NPD7497 Discontinued
0.6816 Remote Similarity NPD6232 Discontinued
0.6811 Remote Similarity NPD8312 Approved
0.6811 Remote Similarity NPD8313 Approved
0.681 Remote Similarity NPD6355 Discontinued
0.6805 Remote Similarity NPD643 Clinical (unspecified phase)
0.6802 Remote Similarity NPD7239 Suspended
0.68 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6792 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6786 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6786 Remote Similarity NPD4110 Phase 3
0.6782 Remote Similarity NPD7411 Suspended
0.678 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6765 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6763 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6763 Remote Similarity NPD3226 Approved
0.6752 Remote Similarity NPD1608 Approved
0.6748 Remote Similarity NPD4140 Approved
0.6747 Remote Similarity NPD1551 Phase 2
0.6744 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6743 Remote Similarity NPD1934 Approved
0.6737 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6723 Remote Similarity NPD7768 Phase 2
0.6723 Remote Similarity NPD3882 Suspended
0.6721 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6705 Remote Similarity NPD8455 Phase 2
0.6703 Remote Similarity NPD7240 Approved
0.6687 Remote Similarity NPD8032 Phase 2
0.6686 Remote Similarity NPD3750 Approved
0.6685 Remote Similarity NPD3749 Approved
0.6685 Remote Similarity NPD7074 Phase 3
0.6667 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1247 Approved
0.6667 Remote Similarity NPD5402 Approved
0.6667 Remote Similarity NPD970 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6653 Approved
0.6648 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6648 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6648 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6648 Remote Similarity NPD6166 Phase 2
0.6647 Remote Similarity NPD6100 Approved
0.6647 Remote Similarity NPD2796 Approved
0.6647 Remote Similarity NPD5403 Approved
0.6647 Remote Similarity NPD6099 Approved
0.663 Remote Similarity NPD7229 Phase 3
0.663 Remote Similarity NPD7054 Approved
0.6628 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6628 Remote Similarity NPD5401 Approved
0.6627 Remote Similarity NPD1243 Approved
0.661 Remote Similarity NPD1465 Phase 2
0.6607 Remote Similarity NPD2346 Discontinued
0.6607 Remote Similarity NPD1471 Phase 3
0.6606 Remote Similarity NPD5735 Approved
0.6605 Remote Similarity NPD6832 Phase 2
0.6596 Remote Similarity NPD8407 Phase 2
0.6595 Remote Similarity NPD7472 Approved
0.6593 Remote Similarity NPD3926 Phase 2
0.659 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6588 Remote Similarity NPD7003 Approved
0.6587 Remote Similarity NPD3748 Approved
0.6587 Remote Similarity NPD7033 Discontinued
0.6578 Remote Similarity NPD7808 Phase 3
0.6575 Remote Similarity NPD6959 Discontinued
0.6568 Remote Similarity NPD1549 Phase 2
0.6561 Remote Similarity NPD17 Approved
0.6548 Remote Similarity NPD2935 Discontinued
0.6548 Remote Similarity NPD2438 Suspended
0.6545 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6538 Remote Similarity NPD7315 Approved
0.6534 Remote Similarity NPD7028 Phase 2
0.6529 Remote Similarity NPD2800 Approved
0.6526 Remote Similarity NPD8150 Discontinued
0.6524 Remote Similarity NPD7251 Discontinued
0.6524 Remote Similarity NPD8368 Discontinued
0.6517 Remote Similarity NPD2801 Approved
0.6509 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6509 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6509 Remote Similarity NPD2344 Approved
0.6491 Remote Similarity NPD8166 Discontinued
0.6489 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6485 Remote Similarity NPD6663 Approved
0.6471 Remote Similarity NPD6797 Phase 2
0.6463 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6456 Remote Similarity NPD1778 Approved
0.6453 Remote Similarity NPD6190 Approved
0.6452 Remote Similarity NPD8470 Clinical (unspecified phase)
0.645 Remote Similarity NPD4477 Approved
0.645 Remote Similarity NPD4476 Approved
0.6444 Remote Similarity NPD7057 Phase 3
0.6444 Remote Similarity NPD7058 Phase 2
0.6438 Remote Similarity NPD3972 Approved
0.6437 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6429 Remote Similarity NPD7097 Phase 1
0.6424 Remote Similarity NPD6798 Discontinued
0.6424 Remote Similarity NPD3268 Approved
0.6424 Remote Similarity NPD3764 Approved
0.6424 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6424 Remote Similarity NPD2313 Discontinued
0.642 Remote Similarity NPD6362 Approved
0.642 Remote Similarity NPD2797 Approved
0.6418 Remote Similarity NPD7999 Approved
0.6414 Remote Similarity NPD4107 Approved
0.6407 Remote Similarity NPD230 Phase 1
0.6407 Remote Similarity NPD447 Suspended
0.6404 Remote Similarity NPD6385 Approved
0.6404 Remote Similarity NPD6386 Approved
0.64 Remote Similarity NPD7680 Approved
0.6398 Remote Similarity NPD7177 Discontinued
0.6395 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6391 Remote Similarity NPD4308 Phase 3
0.6391 Remote Similarity NPD1510 Phase 2
0.6389 Remote Similarity NPD5353 Approved
0.6386 Remote Similarity NPD6233 Phase 2
0.638 Remote Similarity NPD5647 Approved
0.6379 Remote Similarity NPD1511 Approved
0.6378 Remote Similarity NPD4575 Clinical (unspecified phase)
0.6369 Remote Similarity NPD1607 Approved
0.6364 Remote Similarity NPD7095 Approved
0.6359 Remote Similarity NPD5710 Approved
0.6359 Remote Similarity NPD5711 Approved
0.6358 Remote Similarity NPD3887 Approved
0.6358 Remote Similarity NPD2309 Approved
0.6358 Remote Similarity NPD1283 Approved
0.635 Remote Similarity NPD3057 Approved
0.6347 Remote Similarity NPD4060 Phase 1
0.6347 Remote Similarity NPD2979 Phase 3
0.6347 Remote Similarity NPD1240 Approved
0.6341 Remote Similarity NPD5736 Approved
0.6329 Remote Similarity NPD9545 Approved
0.6329 Remote Similarity NPD7930 Approved
0.6324 Remote Similarity NPD5242 Approved
0.6318 Remote Similarity NPD7435 Discontinued
0.6313 Remote Similarity NPD7615 Clinical (unspecified phase)
0.631 Remote Similarity NPD3751 Discontinued
0.631 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6307 Remote Similarity NPD1512 Approved
0.63 Remote Similarity NPD4482 Phase 3
0.6298 Remote Similarity NPD7047 Phase 3
0.6298 Remote Similarity NPD5616 Clinical (unspecified phase)
0.6296 Remote Similarity NPD5327 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data